The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| PROTEON THERAPEUTICS INC | COM | 74371L109 | 772 | 315,101 | SH | DFND | 1 | 315,101 | 0 | 0 | |
| VERASTEM INC | COM | 92337C104 | 8,190 | 1,190,358 | SH | DFND | 1 | 1,190,358 | 0 | 0 | |
| ALLENA PHARMACEUTICALS, INC. | COM | 018119107 | 29,492 | 2,263,365 | SH | DFND | 1 | 2,263,365 | 0 | 0 | |
| DOCUSIGN INC. | COM | 256163106 | 45,272 | 925,000 | SH | DFND | 1 | 925,000 | 0 | 0 | |